Synthomer (SYNT) Competitors GBX 99.70 -2.90 (-2.83%) As of 12:21 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock SYNT vs. SCPA, ESNT, ZTF, TET, IOF, HAYD, WCH, DCTA, ITX, and HDDShould you be buying Synthomer stock or one of its competitors? The main competitors of Synthomer include Scapa Group (SCPA), Essentra (ESNT), Zotefoams (ZTF), Treatt (TET), Iofina (IOF), Haydale Graphene Industries (HAYD), Wilmcote Holdings plc (WCH.L) (WCH), Directa Plus (DCTA), Itaconix (ITX), and Hardide (HDD). These companies are all part of the "specialty chemicals" industry. Synthomer vs. Its Competitors Scapa Group Essentra Zotefoams Treatt Iofina Haydale Graphene Industries Wilmcote Holdings plc (WCH.L) Directa Plus Itaconix Hardide Synthomer (LON:SYNT) and Scapa Group (LON:SCPA) are both small-cap basic materials companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, media sentiment, valuation and earnings. Is SYNT or SCPA more profitable? Scapa Group has a net margin of 0.00% compared to Synthomer's net margin of -4.40%. Scapa Group's return on equity of 0.00% beat Synthomer's return on equity.Company Net Margins Return on Equity Return on Assets Synthomer-4.40% -7.52% -0.28% Scapa Group N/A N/A N/A Which has higher valuation & earnings, SYNT or SCPA? Scapa Group has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Scapa Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSynthomer£1.87B0.09-£82.04M-£49.90-2.00Scapa Group£281.80M0.00N/A-£29.30N/A Does the media refer more to SYNT or SCPA? In the previous week, Synthomer's average media sentiment score of 0.00 equaled Scapa Group'saverage media sentiment score. Company Overall Sentiment Synthomer Neutral Scapa Group Neutral Do insiders and institutionals have more ownership in SYNT or SCPA? 43.8% of Synthomer shares are held by institutional investors. 28.0% of Synthomer shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts recommend SYNT or SCPA? Synthomer presently has a consensus target price of GBX 212.50, suggesting a potential upside of 113.14%. Given Synthomer's stronger consensus rating and higher possible upside, research analysts clearly believe Synthomer is more favorable than Scapa Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synthomer 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Scapa Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummarySynthomer beats Scapa Group on 7 of the 11 factors compared between the two stocks. Get Synthomer News Delivered to You Automatically Sign up to receive the latest news and ratings for SYNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SYNT vs. The Competition Export to ExcelMetricSynthomerSpecialty Chemicals IndustryMaterials SectorLON ExchangeMarket Cap£163.49M£8.08B£3.24B£3.00BDividend Yield28.47%3.52%5.16%5.02%P/E Ratio-2.0012.44112.75169.74Price / Sales0.0959.6128,617,172,096,874,800.00285,731.24Price / Cash2.2819.2523.8827.97Price / Book0.154.426.054.61Net Income-£82.04M£220.83M£147.94M£5.90B7 Day Performance5.95%-0.07%1.87%2.60%1 Month Performance-17.05%2.08%4.86%8.73%1 Year Performance-62.52%-9.15%23.97%64.80% Synthomer Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SYNTSynthomerN/AGBX 99.70-2.8%GBX 212.50+113.1%-62.9%£163.49M£1.87B-2.004,200SCPAScapa GroupN/AN/AN/AN/A£402.98M£281.80M-7.321,461ESNTEssentra1.7076 of 5 starsGBX 109.88-1.2%GBX 206.67+88.1%-28.2%£315.84M£309.74M90.52350Gap UpZTFZotefoamsN/AGBX 316flatN/A-37.4%£151.99M£131.66M15.30549News CoverageTETTreatt2.6415 of 5 starsGBX 250+0.8%GBX 650+160.0%-44.9%£151.15M£142.31M13.51350Dividend IncreaseIOFIofina2.1884 of 5 starsGBX 23.75-2.1%GBX 36.25+52.6%+11.9%£57.02M£61.34M16.6795News CoverageHAYDHaydale Graphene IndustriesN/AGBX 0.68+4.8%N/A+122.1%£25.60M£14.20M-1.4267Gap UpWCHWilmcote Holdings plc (WCH.L)N/AN/AN/AN/A£20.13MN/A-5.003DCTADirecta PlusN/AGBX 12.30-3.5%N/A-37.6%£16.55M£20.29M-2.19187Gap UpITXItaconixN/AGBX 120-5.1%N/A-8.3%£16.18M£5.28M-10.8617Positive NewsHDDHardideN/AGBX 8.40+1.8%N/A+12.0%£6.62M£6.11M-3.5146 Related Companies and Tools Related Companies Scapa Group Alternatives Essentra Alternatives Zotefoams Alternatives Treatt Alternatives Iofina Alternatives Haydale Graphene Industries Alternatives Wilmcote Holdings plc (WCH.L) Alternatives Directa Plus Alternatives Itaconix Alternatives Hardide Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:SYNT) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBuffett’s Little-Known Succession PlanYou could miss out on millions buying a house - even if prices rise Joel Litman is a millionaire member of ...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synthomer plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Synthomer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
